Helicobacter pylori clearance and serum gastrin and pepsinogen I concentrations in omeprazole treatment of duodenal ulcer patients

被引：0
|
作者：
C. T. Lee
B. I. T. Kuo
C. Y. Chen
F. Y. Chang
S. D. Lee
机构：
[1] Division of Gastroenterology,
[2] Department of Medicine,undefined
[3] Veterans General Hospital,undefined
[4] Taipei and National Yang-Ming University School of Medicine,undefined
[5] Taipei,undefined
[6] Taiwan,undefined
[7] Republic of China,undefined
[8] Division of Gastroenterology,undefined
[9] Veterans General Hospital,undefined
[10] Taipei,undefined
[11] No. 201,undefined
[12] Section 2,undefined
[13] Shih-Pai Road,undefined
[14] Taipei,undefined
[15] Taiwan,undefined
[16] 11217,undefined
[17] Republic of China Tel.: +886-2-28757308; Fax: +886-2-28739318,undefined
来源：
European Journal of Clinical Pharmacology | 1999年 / 54卷
关键词：
Key words Gastrin; Pepsinogen I; Duodenal ulcer; Omeprazole; Helicobacter pylori;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: To determine which demographic factors may influence serum gastrin and pepsinogen I (PGI) levels in duodenal ulcer patients undergoing omeprazole treatment.
引用
收藏
页码：817 / 820
页数：3
相关论文
共 50 条
  • [21] Changes of gastrin secretion during omeprazole therapy in patients with duodenal ulcer after eradication of Helicobacter pylori infection.
    Hirakawa, R
    Yoshida, Y
    Yamanaka, T
    Imawari, M
    GASTROENTEROLOGY, 1999, 116 (04) : A187 - A187
  • [22] EFFECT OF ERADICATION OF HELICOBACTER-PYLORI ON SERUM PEPSINOGEN-I, GASTRIN, AND INSULIN IN DUODENAL-ULCER PATIENTS - A 12-MONTH FOLLOW-UP-STUDY
    CHEN, TS
    TSAY, SH
    CHANG, FY
    LEE, SD
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1994, 89 (09): : 1511 - 1514
  • [23] RP 40749 IN THE TREATMENT OF DUODENAL-ULCER AND ITS INFLUENCE ON SERUM GASTRIN, SERUM PEPSINOGEN-I AND GASTRIN CONTENT OF THE ANTRAL MUCOSA
    NELIS, GF
    LAMERS, CBHW
    PALS, G
    GUT, 1985, 26 (10) : 1119 - 1119
  • [24] EFFECT OF OMEPRAZOLE AND LANSOPRAZOLE ON SERUM PEPSINOGEN-A LEVELS IN PATIENTS WITH DUODENAL-ULCER
    CHANG, FY
    LEE, CT
    CHIANG, CY
    LEE, SD
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1995, 56 (09): : 887 - 893
  • [25] HELICOBACTER-PYLORI AND DUODENAL-ULCER TREATED WITH OMEPRAZOLE
    ALFONSO, V
    PONCE, J
    BARRACHINA, M
    ALONSO, C
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1991, 79 (06) : 443 - 444
  • [26] EFFECT OF INTERMITTENT OMEPRAZOLE THERAPY ON BASAL AND POSTPRANDIAL SERUM GASTRIN-CONCENTRATIONS IN DUODENAL-ULCER PATIENTS
    CROBACH, LFSJ
    JANSEN, JBMJ
    LAMERS, CBHW
    GUT, 1986, 27 (10) : 1239 - 1239
  • [27] Duodenal ulcer treatment for Helicobacter pylori
    Greenberg, PD
    Koch, J
    Cello, JP
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (07): : 1473 - 1473
  • [28] Serum levels of pepsinogen I, pepsinogen II, and gastrin-17 in the course of Helicobacter pylori gastritis in pediatrics
    González-Roiz, C
    López-Rodriguez, MJ
    F-Pereira, T
    Zamorano, JDP
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2004, 39 (05): : 569 - 570
  • [29] SERUM PEPSINOGEN-I AND PEPSINOGEN-II CONCENTRATIONS AND IGG ANTIBODY TO HELICOBACTER-PYLORI IN DYSPEPTIC PATIENTS
    BIASCO, G
    PAGANELLI, GM
    VAIRA, D
    HOLTON, J
    DIFEBO, G
    BRILLANTI, S
    MIGLIOLI, M
    BARBARA, L
    SAMLOFF, IM
    JOURNAL OF CLINICAL PATHOLOGY, 1993, 46 (09) : 826 - 828
  • [30] TREATMENT OF HELICOBACTER-PYLORI-ASSOCIATED DUODENAL-ULCER WITH OMEPRAZOLE PLUS ANTIBIOTICS
    MCCARTHY, CJ
    COLLINS, R
    BEATTIE, S
    HAMILTON, H
    OMORAIN, C
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1993, 7 (04) : 463 - 466
12345